San Carlos, California and Seattle-based Nautilus Biotechnology, a developer of a platform for analyzing and quantifying the human proteome, has raised $76 million in funding. Vulcan Capital led the round.
Source: Press Release
Nautilus Biotechnology picks up $76m
San Carlos, California and Seattle-based Nautilus Biotechnology, a developer of a platform for analyzing and quantifying the human proteome, has raised $76 million in funding.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: